Ulteeva Purity™ UHMWPE Fiber and Membrane
Vascular Applications
Getting to the heart of coronary artery disease
50% of men and 30% of women are estimated to develop coronary artery disease (CAD) at some point in their life1. Challenges in treating CAD include navigation, crossing tough, often calcific lesions, minimizing vessel damage, and durability of therapy.
1. Mosca L, et al, Circulation 124(19) 2011.
How do we work to overcome the challenges of coronary artery disease?
At Biomedical, we help create new innovations in coronary disease treatment that are smaller, less intrusive, and more comfortable. We focus on supporting your device development efforts as you strive to improve the clinical effects of coronary interventions.
Discover how we can support you in developing new treatments for vascular disease
Cardiovascular
Working with the healthcare industry to co-create safe, effective, and innovative cardiovascular solutions.
Neurovascular
Pushing technological boundaries in the treatment of neurovascular disease through incredibly small, soft, yet strong biomaterials.
Peripheral vascular
Supporting increased mobility and comfort for patients through biomaterials expertise for next-generation stents.
Innovations that help take on these challenges:
TPU (Biospan®, Bionate®, Carbosil®)
ComfortCoat® DAV Coating
TheraPEA™ Technology
Collagen
An unrivaled biomaterials portfolio
Ready to innovate? Let’s start building your custom solution today. Get in touch with the Biomedical team.
Explore our vascular solutions
-
-
Natural Biomaterials
-
Polyethylenes
-
Polyester Amide
-
Biomedical │ dsm-firmenich Health, Nutrition & Care
-
Expert Services